Pricing Estimates & Optimisation

Client question A global team sought to understand how a novel oncology combination therapy could be priced in Japan, where both components were new to the market. Our approach We assessed precedent for combination treatments and developed structured pricing assumptions to test with payer stakeholders, exploring launch sequence implications. Outcome Recommendations were provided on optimal positioning, premium potential, and how sequencing could impact achievable price. Neurology Market Access Strategy in a Competitive Class Client question A client preparing to launch a third-in-class neurology product sought clarity on pricing potential and drivers of formulary adoption. Our approach We conducted thorough secondary research to formulate our assumptions followed by interviews with former Chuikyo-linked experts, hospital pharmacists, and clinicians on order to understand potential pricing, and drivers for both hospital and physician adoption Outcome Concrete guidance on price optimisation, adoption drivers, differentiation levers, and communication priorities were provided to the client to support with both pricing negotiations and wholesaler education